Evidence map›Paper›PMID 37402303›Full record

ArticleRevista de la Facultad de Ciencias Medicas (Cordoba, Argentina)2023

[Insufficient elevation of TSH before therapy with I131 in a patient with metastatic differentiated thyroid carcinoma]

Luis Agustín Ramírez Stieben, Mariana Queralt, Gustavo Sylvestre Begnis, David Polillo, Ignacio Barrenechea

Open access · diamondAbstract readCase ReportsEnglish Abstract
In one paragraph

Article in Revista de la Facultad de Ciencias Medicas (Cordoba, Argentina), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 81% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 5 institutions in 4 countries.

Luis Agustín Ramírez StiebenUnidad de Tiroides y Paratiroides del Grupo Gamma. ramirez.stieben@gmail.com.
Mariana QueraltServicio de Oncología del Grupo Gamma. marianaq9@hotmail.com.
Gustavo Sylvestre BegnisServicio de Cirugía General del Grupo Gamma. gsylvestrebegnis@grupogamma.com.
David PolilloServicio de Diagnóstico por imágenes del Grupo Gamma . dpolillo@grupogamma.com.
Ignacio BarrenecheaServicio de Neurocirugía del Grupo Gamma. ibarrenechea@grupogamma.com.
Centrus Diagnósticos por Imagem · BRGamma Medica (United States) · USGamma Therapeutics (United States) · USInstituto Gamma · CLPride Foundation · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Guidelines suggest a thyrotropin (TSH) stimulation level ≥30 mIU/l for the administration of 131-iodine (I131) in patients with differentiated thyroid carcinoma (DTC). We present a patient with follicular thyroid carcinoma (FTC), with spinal metastasis as the initial manifestation, who after 6 weeks without levothyroxine did not present an elevation of ≥30 mIU/l of TSH. This situation was interpreted as secondary to the presence of functioning metastases and it was decided, regardless of the TSH level, to administer a therapeutic dose of I131, with iodine-uptake lesions in the liver and spine being confirmed.

Indexed as

IodineThyroid NeoplasmsHumansThyrotropinThyroxineIodineThyrotropinThyroxineiodinethyroid neoplasmsthyrotropine

Identifiers

PMID37402303
PMCPMC10443422
OpenAlexW4383101437

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.